The effect of HPV analysis on the ASC/SIL ratio which is one of the quality control criteria for PAP smears
Objective: The high number of smear tests has a workload on pathologists/cytopathologists, which raises the concern for the quality of diagnoses. The application of high-risk human papillomavirus (hr-HPV) analyses with the PAP smear has begun to contribute to the clinical practice. In this study, we aimed to show the effect of hr-HPV analysis on the results of PAP smear via atypical squamous cell/squamous intraepithelial lesion (ASC/SIL) ratio on the quality standards. Material and Methods: A total of 12799 cervical cytology reports, between 2014-2016, from the Pathology Department of Marmara University Hospital, were included. Between November 2014 and May 2016, hr-HPV analysis was performed on a total of 4307 cases with Hologic Aptima HPV™, USA. Smear diagnoses before and after the start of the HPV test application were recorded. Results: The cytology diagnoses, during when hr-HPV screening was not performed, were: negative for intraepithelial lesion or malignancy (NILM) 99.4%, atypical squamous cells of undetermined significance (ASCUS) 0.6%, low-grade squamous intraepithelial lesion (LSIL) 0.2%, ASC-H 0.04%, and high-grade squamous intraepithelial lesion (HSIL) 0.13%. The cytology diagnoses that were evaluated with HPV test were as follows: NILM 93.67%, ASCUS 2.31%, LSIL 2.82%, ASC-H 0.3%, and HSIL 0.91%. ASC/SIL ratio has been dropped from 1.9 to 0.7 after the initiation of hr-HPV use. Conclusion: During the period without hr-HPV analysis, the ASC/SIL ratio was 1.9. Later with the initiation of hr-HPV screening this ratio decreased to 0.7. This shows that knowing HPV test results affects and improves the quality of the laboratory diagnoses.
___
- Felix JC, Lacey MJ, Miller JD, Lenhart GM, Spitzer M,
Kulkarni R. The clinical and economic benefits of co-testing
versus primary HPV testing for cervical cancer screening:
A modeling analysis. J Women’s Health 2016;25:606-16.doi:
10.1089/jwh.2015.5708
- Wright TC Jr, Stoler MH, Aslam S, Behrens CM. Knowledge
of patients’ human papillomavirus status at the time of
cytologic review significantly affects the performance of
cervical cytology in the ATHENA Study. Am J Clin Pathol
2016;146:391-8.doi: 10.1093/ajcp/aqw125
- Juskevicius R, Zou KH, Cibas ES. An analysis of factors that
influence the ASCUS/SIL ratio of pathologists. Am J Clin
Pathol 2001;116:331-5.doi: 10.1309/0BL4-6H9V-DQVVUGXR
- Alessandra F. Nascimento ESC. The ASC/SIL ratio for
cytopathologists as a quality control measure: A follow-up
study. Am J Clin Pathol 2007;128:653-6. doi: 10.1309/
APTVNLP1P0X00CUQ
- Nayar R, Wilbur D. (Eds) The Bethesda System for reporting
cervical cytology. Switzerland: Springer, 2015. ISBN 978-3-
319-11073-8. doi: 10.1007/978-3-319-11074-5
- Kurman RJ. Specimen adequacy. In: Solomon D, ed. The
Bethesda System for Reporting Cervical/Vaginal Cytologic
Diagnoses. New York, NY: Springer – Verlag, 1994.
- Rebolj JR M, Denton K, Tidy J, et al. Primary cervical screening
with high risk human papillomavirus testing: observational
study. BMJ 2019; 6;364:l240. doi: 10.1136/bmj.l240
- Yang J, Nolte FS, Chajewski OS, et al. Cytology and high risk
HPV testing in cervical cancer screening program: Outcome
of 3-year follow-up in an academic institute. Diagn Cytopathol
2018;46:22-7. doi: 10.1002/dc.23843
- Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-
Based Management Consensus Guidelines Committee. 2019
ASCCP Risk-Based Management Consensus Guidelines
for abnormal cervical cancer screening tests and cancer
precursors. J Low Genit Tract Dis 2020;24:102-31. doi:10.1097/
LGT.000.000.0000000525
- Benoy IH, Broeck DV, Ruymbeke MJ, et al. Prior knowledge
of HPV status improves detection of CIN2 by cytology
screening. Am J Obstet Gynecol 2011;205:1-7.doi: 10.1016/j.
ajog.2011.06.101
- Renshaw AA, Deschênes M, Auger M. ASC/SIL ratio
for cytotechnologists: A surrogate marker of screening
sensitivity. Am J Clin Pathol 2009;131:776-81. doi: 10.1309/
AJCPXANG59GPHJNU
- Commission on Laboratory Accreditation Laboratory
Accreditation Program. Cytopathology checklist. CYP07650
Available at https://elsscaporg/elss/ShowProperty?nodePath=/
UCMCON/Contribution%20Folders/DctmContent/
education/OnlineCourseContent/2017/LAP-